-
1 Comment
Guangdong Biolight Meditech Co., Ltd is currently in a long term downtrend where the price is trading 22.2% below its 200 day moving average.
From a valuation standpoint, the stock is 70.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Guangdong Biolight Meditech Co., Ltd's total revenue rose by 44.3% to $325M since the same quarter in the previous year.
Its net income has increased by 169.3% to $75M since the same quarter in the previous year.
Finally, its free cash flow fell by 101.7% to $-311K since the same quarter in the previous year.
Based on the above factors, Guangdong Biolight Meditech Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE1000015Q4 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 2B |
|---|---|
| Beta | 0.68 |
| PE Ratio | None |
| Target Price | 25 |
| Dividend Yield | None |
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG monitoring equipment, fetal monitors, hemodialysis products, medical products, monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. The company was founded in 1993 and is headquartered in Zhuhai City, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300246.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
